Total Payments
$6,123
2024 Payments
$455.48
Companies
26
Transactions
219
Medicare Patients
1,998
Medicare Billing
$258,454
Payment Breakdown by Category
Food & Beverage$6,108 (99.8%)
Education$15.03 (0.2%)
Payments by Nature
| Nature of Payment | Amount | Transactions | Share |
|---|---|---|---|
| Food and Beverage | $6,108 | 218 | 99.8% |
| Education | $15.03 | 1 | 0.2% |
Top Paying Companies
| Company | Total | Records | Latest Year |
|---|---|---|---|
| Janssen Pharmaceuticals, Inc | $1,391 | 39 | $0 (2024) |
| Novartis Pharmaceuticals Corporation | $946.95 | 37 | $0 (2023) |
| Allergan, Inc. | $445.94 | 19 | $0 (2020) |
| Inari Medical, Inc. | $444.15 | 3 | $0 (2023) |
| E.R. Squibb & Sons, L.L.C. | $357.13 | 19 | $0 (2023) |
| PFIZER INC. | $354.64 | 14 | $0 (2023) |
| ZOLL Services LLC (A/K/A ZOLL LifeCor Corp) | $354.48 | 17 | $0 (2020) |
| AstraZeneca Pharmaceuticals LP | $273.74 | 13 | $0 (2022) |
| Gilead Sciences, Inc. | $253.45 | 6 | $0 (2024) |
| Otsuka America Pharmaceutical, Inc. | $189.49 | 10 | $0 (2019) |
Payment History by Year
| Year | Amount | Transactions | Top Company |
|---|---|---|---|
| 2024 | $455.48 | 12 | Janssen Pharmaceuticals, Inc ($303.15) |
| 2023 | $817.03 | 10 | Inari Medical, Inc. ($425.78) |
| 2022 | $867.99 | 37 | Janssen Pharmaceuticals, Inc ($463.57) |
| 2021 | $710.34 | 29 | Janssen Pharmaceuticals, Inc ($213.17) |
| 2020 | $579.63 | 24 | Mylan Specialty L.P. ($133.94) |
| 2019 | $994.24 | 44 | Novartis Pharmaceuticals Corporation ($243.06) |
| 2018 | $1,184 | 39 | Novartis Pharmaceuticals Corporation ($378.25) |
| 2017 | $514.50 | 24 | ZOLL Services LLC (A/K/A ZOLL LifeCor Corp) ($134.08) |
All Payment Transactions
219 individual payment records from CMS Open Payments — Page 1 of 9
| Date | Company | Product | Nature | Form | Amount | Type |
|---|---|---|---|---|---|---|
| 08/13/2024 | Gilead Sciences, Inc. | — | Food and Beverage | In-kind items and services | $23.79 | General |
| 08/06/2024 | Janssen Pharmaceuticals, Inc | XARELTO (Drug) | Food and Beverage | In-kind items and services | $12.08 | General |
| Category: Cardiovascular & Metabolism | ||||||
| 06/12/2024 | Janssen Biotech, Inc. | RYBREVANT (Drug) | Food and Beverage | In-kind items and services | $20.32 | General |
| Category: Oncology | ||||||
| 06/03/2024 | Janssen Pharmaceuticals, Inc | XARELTO (Drug) | Food and Beverage | In-kind items and services | $149.94 | General |
| Category: Cardiovascular & Metabolism | ||||||
| 04/11/2024 | Janssen Pharmaceuticals, Inc | XARELTO (Drug) | Food and Beverage | In-kind items and services | $12.65 | General |
| Category: Cardiovascular & Metabolism | ||||||
| 04/05/2024 | ABBVIE INC. | DALVANCE (Drug), AVYCAZ, TEFLARO | Food and Beverage | In-kind items and services | $14.94 | General |
| Category: ANTI-INFECTIVE | ||||||
| 03/13/2024 | ABBVIE INC. | TEFLARO (Drug), DALVANCE | Food and Beverage | In-kind items and services | $18.76 | General |
| Category: ANTI-INFECTIVE | ||||||
| 02/22/2024 | ABBVIE INC. | DALVANCE (Drug), TEFLARO | Food and Beverage | In-kind items and services | $19.19 | General |
| Category: ANTI-INFECTIVE | ||||||
| 02/16/2024 | Janssen Pharmaceuticals, Inc | XARELTO (Drug) | Food and Beverage | In-kind items and services | $128.48 | General |
| Category: Cardiovascular & Metabolism | ||||||
| 02/01/2024 | AngioDynamics, Inc. | ANGIOVAC (Device) | Food and Beverage | In-kind items and services | $21.48 | General |
| Category: VIT | ||||||
| 01/30/2024 | ABBVIE INC. | DALVANCE (Drug), AVYCAZ, TEFLARO | Food and Beverage | In-kind items and services | $19.91 | General |
| Category: ANTI-INFECTIVE | ||||||
| 01/09/2024 | ABBVIE INC. | TEFLARO (Drug), AVYCAZ, DALVANCE | Food and Beverage | In-kind items and services | $13.94 | General |
| Category: ANTI-INFECTIVE | ||||||
| 09/25/2023 | E.R. Squibb & Sons, L.L.C. | CAMZYOS (Drug) | Food and Beverage | Cash or cash equivalent | $22.52 | General |
| Category: Cardiovascular | ||||||
| 09/20/2023 | Gilead Sciences, Inc. | Veklury (Drug) | Food and Beverage | In-kind items and services | $30.04 | General |
| Category: COVID-19 | ||||||
| 09/12/2023 | ABBVIE INC. | TEFLARO (Drug) | Food and Beverage | In-kind items and services | $15.03 | General |
| Category: ANTI-INFECTIVE | ||||||
| 08/23/2023 | Inari Medical, Inc. | FLOWTRIEVER CATHETER, S (Device), CT THROMBECTOMY SYSTEM KIT | Food and Beverage | In-kind items and services | $237.18 | General |
| Category: VTE | ||||||
| 07/14/2023 | Novartis Pharmaceuticals Corporation | ENTRESTO (Drug), LEQVIO | Food and Beverage | In-kind items and services | $21.04 | General |
| Category: Cardiology/Vascular Diseases | ||||||
| 05/10/2023 | Gilead Sciences, Inc. | — | Food and Beverage | In-kind items and services | $21.23 | General |
| 02/28/2023 | Gilead Sciences, Inc. | Veklury (Drug) | Food and Beverage | In-kind items and services | $125.00 | General |
| Category: COVID-19 | ||||||
| 02/01/2023 | PFIZER INC. | VYNDAMAX (Drug) | Food and Beverage | In-kind items and services | $23.06 | General |
| Category: CARDIOVASCULAR | ||||||
| 01/26/2023 | Inari Medical, Inc. | FLOWTRIEVER CATHETER, S (Device), CT THROMBECTOMY SYSTEM KIT | Food and Beverage | In-kind items and services | $188.60 | General |
| Category: VTE | ||||||
| 01/26/2023 | Boston Scientific Corporation | — | Food and Beverage | In-kind items and services | $133.33 | General |
| Category: General - Vascular Intervention_PI | ||||||
| 10/20/2022 | Janssen Pharmaceuticals, Inc | XARELTO (Drug) | Food and Beverage | In-kind items and services | $38.58 | General |
| Category: Cardiovascular & Metabolism | ||||||
| 10/12/2022 | Gilead Sciences, Inc. | — | Food and Beverage | In-kind items and services | $31.18 | General |
| 09/27/2022 | Merck Sharp & Dohme LLC | DIFICID (Drug), ZERBAXA, RECARBRIO | Food and Beverage | In-kind items and services | $23.82 | General |
| Category: INFECTIOUS DISEASE | ||||||
Medicare Billing by Year
| Year | Procedures | Beneficiaries | Services | Submitted | Medicare Paid |
|---|---|---|---|---|---|
| 2023 | 5 | 484 | 743 | $381,222 | $57,401 |
| 2022 | 4 | 533 | 896 | $348,566 | $71,649 |
| 2021 | 6 | 468 | 805 | $335,505 | $66,445 |
| 2020 | 6 | 513 | 866 | $313,855 | $62,958 |
Total Patients
1,998
Total Services
3,310
Medicare Billing
$258,454
Procedure Codes
21
All Medicare Procedures & Services
21 procedure records from CMS Medicare Utilization
| HCPCS | Description | Setting | Year | Patients | Services | Charges | Medicare Paid | Ratio |
|---|---|---|---|---|---|---|---|---|
| 99232 | Subsequent hospital care with moderate levelof medical decision making, if using time, at least 35 minutes | Facility | 2023 | 165 | 372 | $138,336 | $21,911 | 15.8% |
| 99239 | Hospital discharge day management, more than 30 minutes | Facility | 2023 | 146 | 148 | $80,728 | $12,570 | 15.6% |
| 99233 | Subsequent hospital care with moderate levelof medical decision making, if using time, at least 50 minutes | Facility | 2023 | 75 | 124 | $68,226 | $11,011 | 16.1% |
| 99223 | Initial hospital care with moderate level of medical decision making, if using time, at least 75 minutes | Facility | 2023 | 71 | 72 | $73,674 | $9,301 | 12.6% |
| 99222 | Initial hospital care with straightforward or low-level medical decision making, if using time, at least 55 minutes | Facility | 2023 | 27 | 27 | $20,258 | $2,609 | 12.9% |
| 99233 | Follow-up hospital inpatient care per day, typically 35 minutes | Facility | 2022 | 168 | 426 | $161,454 | $32,675 | 20.2% |
| 99223 | Initial hospital inpatient care per day, typically 70 minutes | Facility | 2022 | 106 | 108 | $76,140 | $15,961 | 21.0% |
| 99239 | Hospital discharge day management, more than 30 minutes | Facility | 2022 | 151 | 152 | $52,592 | $11,946 | 22.7% |
| 99232 | Follow-up hospital inpatient care per day, typically 25 minutes | Facility | 2022 | 108 | 210 | $58,380 | $11,067 | 19.0% |
| 99233 | Subsequent hospital inpatient care, typically 35 minutes per day | Facility | 2021 | 165 | 436 | $165,244 | $34,603 | 20.9% |
| 99239 | Hospital discharge day management, more than 30 minutes | Facility | 2021 | 124 | 129 | $44,634 | $10,490 | 23.5% |
| 99223 | Initial hospital inpatient care, typically 70 minutes per day | Facility | 2021 | 63 | 63 | $44,415 | $9,612 | 21.6% |
| 99232 | Subsequent hospital inpatient care, typically 25 minutes per day | Facility | 2021 | 81 | 142 | $39,476 | $7,779 | 19.7% |
| 99220 | Hospital observation care, typically 70 minutes | Facility | 2021 | 24 | 24 | $35,400 | $3,353 | 9.5% |
| 99217 | Hospital observation care on day of discharge | Facility | 2021 | 11 | 11 | $6,336 | $607.20 | 9.6% |
| 99232 | Subsequent hospital inpatient care, typically 25 minutes per day | Facility | 2020 | 174 | 410 | $113,980 | $22,782 | 20.0% |
| 99233 | Subsequent hospital inpatient care, typically 35 minutes per day | Facility | 2020 | 120 | 233 | $88,307 | $18,678 | 21.2% |
| 99239 | Hospital discharge day management, more than 30 minutes | Facility | 2020 | 151 | 155 | $53,630 | $12,686 | 23.7% |
| 99223 | Initial hospital inpatient care, typically 70 minutes per day | Facility | 2020 | 34 | 34 | $23,970 | $5,497 | 22.9% |
| 99220 | Hospital observation care, typically 70 minutes | Facility | 2020 | 16 | 16 | $23,600 | $2,311 | 9.8% |
| 99217 | Hospital observation care on day of discharge | Facility | 2020 | 18 | 18 | $10,368 | $1,003 | 9.7% |
About Dr. Ravi Mishra, MD
Dr. Ravi Mishra, MD is a Hospitalist healthcare provider based in Nashville, Tennessee. This provider has been registered with the National Plan and Provider Enumeration System (NPPES) since 03/27/2013. The National Provider Identifier (NPI) number assigned to this provider is 1093058018.
According to the Centers for Medicare & Medicaid Services (CMS) Open Payments database, Dr. Ravi Mishra, MD has received a total of $6,123 in payments from pharmaceutical and medical device companies, with $455.48 received in 2024. These payments were reported across 219 transactions from 26 companies. The most common payment nature is "Food and Beverage" ($6,108).
As a Medicare-enrolled provider, Mishra has provided services to 1,998 Medicare beneficiaries, totaling 3,310 services with total Medicare billing of $258,454. Data is available for 4 years (2020–2023), covering 21 distinct procedure/service records.
Ad
Practice Information
- Specialty Hospitalist
- Location Nashville, TN
- Active Since 03/27/2013
- Last Updated 12/31/2021
- Taxonomy Code 208M00000X
- Entity Type Individual
- NPI Number 1093058018
Products in Payments
- XARELTO (Drug) $1,391
- ENTRESTO (Drug) $946.95
- ELIQUIS (Drug) $553.08
- FLOWTRIEVER CATHETER, S (Device) $444.15
- LifeVest (Device) $354.48
- AVYCAZ (Drug) $298.79
- ANDEXXA (Biological) $205.20
- SAMSCA (Drug) $189.49
- TEFLARO (Drug) $158.50
- Veklury (Drug) $155.04
- BRILINTA (Drug) $139.83
- Yupelri (Drug) $133.94
- DALVANCE (Drug) $132.39
- Kcentra (Biological) $76.37
- XIFAXAN (Drug) $73.75
- CHANTIX (Drug) $63.98
- DIFICID (Drug) $61.14
- Nephrocheck (Device) $46.52
- ANDEXXA (Drug) $44.17
- HeartMate 3 Left Ventricular Dev (Device) $38.74
Explore
Data Sources
Provider data from NPPES. Payment data from CMS Open Payments. Medicare data from CMS Medicare Provider Utilization. All data is public and updated periodically.
Hospitalist Doctors in Nashville
Dr. Olalekan Oluwole, Md, Mph, MD, MPH
Hospitalist — Payments: $219,617
Hospitalist $219,617
Andrew Zurick, M.d, M.D
Hospitalist — Payments: $171,446
Hospitalist $171,446
Dr. Sonya Reid, Md, MD
Hospitalist — Payments: $99,563
Hospitalist $99,563
Christopher Hoffman, Md, MD
Hospitalist — Payments: $43,485
Hospitalist $43,485
Courtney Havill, Fnp-C, FNP-C
Hospitalist — Payments: $3,934
Hospitalist $3,934
Philip Kuo, Md, MD
Hospitalist — Payments: $3,825
Hospitalist $3,825